Literature DB >> 28195638

Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer.

Miren Taberna1,2,3, Ronald C Inglehart4, Robert K L Pickard5, Carole Fakhry6, Amit Agrawal7, Mira L Katz8,9, Maura L Gillison5.   

Abstract

BACKGROUND: Sexual behavior and oral human papillomavirus (HPV) infection are risk factors for oral squamous cell carcinoma (OSCC). The effects of OSCC diagnosis and treatment on subsequent relationship stress and sexual behavior are unknown.
METHODS: Incident cases of HPV-positive or HPV-negative OSCC in patients who had a partnered relationship and partners of patients with oropharyngeal cancer were eligible for a study in which surveys were administered at diagnosis and at the 6-month follow-up time point to assess relationship distress, HPV transmission and concerns about health consequences, and sexual behavior. The frequency distributions of responses, stratified by tumor HPV status, were compared at baseline and follow-up.
RESULTS: In total, 262 patients with OSCC and 81 partners were enrolled. Among the patients, 142 (54.2%) had HPV-positive OSCC, and 120 (45.8%) had HPV-negative OSCC. Relationship distress was infrequently reported, and 69% of patients felt that their relationship had strengthened since the cancer diagnosis. Both HPV-positive patients (25%) and their partners (14%) reported feelings of guilt or responsibility for the diagnosis of an HPV-caused cancer. Concern over sexual, but not nonsexual, HPV transmission to partners was reported by 50%. Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status. From baseline to 6 months, significant increases in abstinence from vaginal sex (from 10% to 34%; P < .01) and oral sex (from 25% to 80%; P < .01) were reported.
CONCLUSIONS: Diagnosis and treatment of OSCC are associated with significant declines in the frequency of vaginal and oral sex, regardless of tumor HPV status. Sexual behavior is an important quality-of-life outcome to assess within clinical trials. [See related editorial on pages 000-000, this issue.] Cancer 2017.
© 2017 American Cancer Society. Cancer 2017;123:1156-1165. © 2016 American Cancer Society. © 2017 American Cancer Society.

Entities:  

Keywords:  HPV worries; head and neck cancer; human papillomavirus (HPV) transmission; mouth neoplasm; oral cancer; patient relationships; quality of life; sexual behavior

Mesh:

Year:  2017        PMID: 28195638     DOI: 10.1002/cncr.30564

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

Authors:  Melina J Windon; Gypsyamber D'Souza; Carole Fakhry
Journal:  Future Oncol       Date:  2018-09-28       Impact factor: 3.404

2.  Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment.

Authors:  Melina J Windon; Carole Fakhry; Farhoud Faraji; Tanya Troy; Christine G Gourin; Ana P Kiess; Wayne Koch; David W Eisele; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2019-06-04       Impact factor: 5.337

3.  A descriptive study of human papilloma virus in upper aero-digestive squamous cell carcinoma at Uganda cancer institute assessed by P16 immunohistochemistry.

Authors:  Fiona Kabagenyi; Jeff Otiti; Justine Namwagala; Adriane Kamulegeya; Sam Kalungi
Journal:  Cancers Head Neck       Date:  2020-08-27

Review 4.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

5.  Priorities, concerns, and regret among patients with head and neck cancer.

Authors:  Melina J Windon; Gypsyamber D'Souza; Farhoud Faraji; Tanya Troy; Wayne M Koch; Christine G Gourin; Ana P Kiess; Karen T Pitman; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

6.  Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study.

Authors:  Melina J Windon; Daisy Le; Gypsyamber D'Souza; Elaine Bigelow; Karen Pitman; Emily Boss; David W Eisele; Carole Fakhry
Journal:  Oral Oncol       Date:  2020-10-30       Impact factor: 5.337

7.  Psychosocial impact of human papillomavirus-related head and neck cancer on patients and their partners: A qualitative interview study.

Authors:  Rachael H Dodd; Alice S Forster; Laura A V Marlow; Jo Waller
Journal:  Eur J Cancer Care (Engl)       Date:  2019-01-24       Impact factor: 2.520

8.  Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort.

Authors:  Silvia Carlos; Cristina López-Del Burgo; Adolphe Ndarabu; Alfonso Osorio; Anaïs Rico-Campà; Gabriel Reina; Eduardo Burgueño; Jokin de Irala
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

Review 9.  The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer.

Authors:  Hao-Fan Wang; Sha-Sha Wang; Ya-Jie Tang; Yu Chen; Min Zheng; Ya-Ling Tang; Xin-Hua Liang
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

10.  Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review.

Authors:  Anna Starzyńska; Aleksandra Sejda; Paulina Adamska; Giulia Marvaso; Monika Sakowicz-Burkiewicz; Łukasz Adamski; Barbara A Jereczek-Fossa
Journal:  Arch Med Sci       Date:  2020-11-13       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.